PDCD1 and neoplasm: Furthermore, the triple therapy of DC vaccine, PD-1 blockade and lenalidomide in the MM mouse model potently inhibited the growth of tumor cells, with enhancing functional activity of cytotoxic T lymphocytes and NK cells, synergistically enhancing anti-tumor immunity (109).